Loading company…
Waterstone Pharmaceuticals develops and produces drugs for metabolic diseases such as diabetic kidney disease, hyperuricemia and gout.
Waterstone Pharmaceuticals researches and develops pharmaceutical products for metabolic diseases, including diabetic kidney disease, hyperuricemia and gout. Founded in 2008 in Carmel, US, the company sells mainly to healthcare providers, hospitals and pharmacies through B2B deals and wholesalers. Founder Faming Zhang. It has completed 2 deals, most recently USD 19 mn in venture debt on September 26, 2012. The company is at Series B stage and plans new products and entry into Europe and Asia, with a presence targeted by 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in